<p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/GettyImages-2260256868-430x241.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="430" height="241" original-src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/GettyImages-2260256868-430x241.jpg"/></p>
<p>葛兰素史克的疫苗自 2015 年以来一直在英国的婴儿常规免疫计划中使用，并导致接种年龄组的感染减少了 75%。照片由 Nikolas Kokovlis/NurPhoto 通过 Getty Images 提供。</p>
<p>在英格兰肯特地区持续爆发脑膜炎球菌病的情况下，葛兰素史克表示，如果需要，将准备与英国卫生当局合作，扩大其脑膜炎疫苗在国家免疫计划中的使用。</p>
<p>该制药公司的 MenB 疫苗，品牌名为 Bexsero，目前仅在英国的婴儿免疫计划中使用。自 2015 年以来，它一直被纳入英国的婴儿常规免疫计划。然而，这意味着许多人，包括在此日期之前出生的青少年，除非私下接种疫苗，否则没有得到保护。</p>
<h3>深入了解 GlobalData</h3>
<ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<p>报告</p>
<h4>NPVM: GSK plc 的 AFX-3772</h4>
<ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<p>报告</p>
<h4>NPVM: GSK plc 的 Men ABCWY</h4>
<h5>深入了解 GlobalData</h5>
<p>商业智能的黄金标准。</p>
<p>了解更多</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg"/></p>
<h4>发现有效的 B2B 营销</h4>
<p>结合商业智能和编辑卓越，覆盖 36 个领先媒体平台的专业人士。</p>
<p>了解更多</p>
<p>肯特一所大学的脑膜炎球菌病持续爆发，导致政府正在评估疫苗的更广泛使用。此次疫情导致两人死亡，20 个潜在病例。英国卫生安全局（UKHSA）表示，将启动针对性疫苗接种计划，首先针对居住在肯特大学的学生。卫生部长 Wes Streeting 在下议院表示，他将要求政府顾问考虑将现有免疫计划扩展到婴儿以外的年龄组，例如青少年。</p>
<p>葛兰素史克的一位发言人告诉《制药技术》：&#34;我们准备与英国卫生当局就 MenB 疫苗/Bexsero 的更广泛使用进行接洽，以应对肯特的当前疫情。任何此类提案的细节尚未确定，因此我们目前无法进一步评论。&#34;</p>
<p>脑膜炎球菌病是由侵袭性感染引起的，病原体为_奈瑟氏脑膜炎球菌_。细菌通过呼吸道分泌物的呼气飞沫或与感染者的呼吸道分泌物直接接触传播。青少年群体，如学生，由于社交文化和群居生活安排，感染风险更高。</p>
<p>MenB 疫苗通过两剂接种，自 2015 年以来一直在英国的婴儿常规免疫计划中使用，并导致接种组的感染减少了 75%。Bexsero 旨在对导致脑膜炎球菌病的大多数 MenB 菌株提供广泛的保护，尽管由于新突变的出现，它无法提供完全的保护。</p>
<p>抗生素仍然是限制侵袭性脑膜炎球菌病传播的最有效治疗方法。UKHSA 表示，肯特地区已向学生及其密切接触者提供了超过 2500 剂疫苗。</p>
<p>在评论当前疫情时，UKHSA 的负责人 Susan Hopkins 表示：&#34;这看起来像是一个超级传播事件，正在大学宿舍内持续传播。&#34;</p>
<h2>私营部门的供应减少</h2>
<p>自 2013 年疫苗首次获批以来，葛兰素史克的 MenB 疫苗也一直可以私下接种。自肯特疫情以来，私人诊所和药店报告了对该疫苗需求的激增。</p>
<p>一位希望保持匿名的伦敦私人诊所的全科医生告诉《制药技术》：&#34;我们接到大量电话。我们所有的疫苗供应现在都用完了，无法再获得更多。&#34;</p>
<p>该诊所表示收到了来自其医疗供应商的警报，称：&#34;我们已经售罄 Bexsero 疫苗。目前，我们不知道何时能够获得更多，因为优先权给予 NHS。&#34;</p>
<p>与此同时，连锁药店 Superdrug 报告称，疫苗的预约需求增加了 65 倍。</p>
<p>“目前脑膜炎 B 疫苗存在全国性短缺，库存有限。我们正在与供应商合作以确保更多剂量，” 该公司在一份声明中表示。</p>

葛兰素史克

<p>葛兰素史克（GSK）准备在英国肯特地区的脑膜炎球菌疾病爆发期间扩大其脑膜炎疫苗接种计划。卫生部长韦斯·斯特里廷（Wes Streeting）正在考虑将疫苗的接种范围扩大到青少年，因为目前的接种计划仅覆盖婴儿。MenB 疫苗 Bexsero 自 2015 年以来已成为英国免疫计划的一部分，感染率降低了 75%。目前已报告两例死亡和 20 例潜在病例，针对大学生的定向接种计划即将开始。疫苗需求激增，导致私人诊所和药店出现短缺</p>

<p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/GettyImages-2260256868-430x241.jpg" alt="" original-src="https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/GettyImages-2260256868-430x241.jpg"/></p>
<p>GSK’s vaccine has been on the UK’s routine immunisation programme for babies since 2015 and has led to a 75% reduction in infections in vaccinated age groups. Photo by Nikolas Kokovlis/NurPhoto via Getty Images.</p>
<div class="lb-trans"><p>葛兰素史克的疫苗自 2015 年以来一直在英国的婴儿常规免疫计划中使用，并导致接种年龄组的感染减少了 75%。照片由 Nikolas Kokovlis/NurPhoto 通过 Getty Images 提供。</p>
</div><p>Amid an ongoing outbreak of meningococcal disease in Kent, England, GSK has said it is ready to work with UK health authorities to widen its meningitis vaccine’s slot on the country’s immunisation schedule, if needed.</p>
<div class="lb-trans"><p>在英格兰肯特地区持续爆发脑膜炎球菌病的情况下，葛兰素史克表示，如果需要，将准备与英国卫生当局合作，扩大其脑膜炎疫苗在国家免疫计划中的使用。</p>
</div><p>The drugmaker’s MenB vaccine, known under the brand name Bexsero, is currently on the UK schedule for infants only.  It has been used in the UK’s routine immunisation programme for babies since 2015. However, this means many people, including teenagers born before this date, are not protected unless they obtained the vaccine privately.</p>
<div class="lb-trans"><p>该制药公司的 MenB 疫苗，品牌名为 Bexsero，目前仅在英国的婴儿免疫计划中使用。自 2015 年以来，它一直被纳入英国的婴儿常规免疫计划。然而，这意味着许多人，包括在此日期之前出生的青少年，除非私下接种疫苗，否则没有得到保护。</p>
</div><h3>Go deeper with GlobalData</h3>
<div class="lb-trans"><h3>深入了解 GlobalData</h3>
</div><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<div class="lb-trans"><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
</div><p>Reports</p>
<div class="lb-trans"><p>报告</p>
</div><h4>NPVM: GSK plc's AFX-3772</h4>
<div class="lb-trans"><h4>NPVM: GSK plc 的 AFX-3772</h4>
</div><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<div class="lb-trans"><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
</div><p>Reports</p>
<div class="lb-trans"><p>报告</p>
</div><h4>NPVM: GSK plc's Men ABCWY</h4>
<div class="lb-trans"><h4>NPVM: GSK plc 的 Men ABCWY</h4>
</div><h5>Go deeper with GlobalData</h5>
<div class="lb-trans"><h5>深入了解 GlobalData</h5>
</div><p>The gold standard of business intelligence.</p>
<div class="lb-trans"><p>商业智能的黄金标准。</p>
</div><p>Find out more</p>
<div class="lb-trans"><p>了解更多</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg" alt="" original-src="https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg"/></p>
<h4>Discover B2B Marketing That Performs</h4>
<div class="lb-trans"><h4>发现有效的 B2B 营销</h4>
</div><p>Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.</p>
<div class="lb-trans"><p>结合商业智能和编辑卓越，覆盖 36 个领先媒体平台的专业人士。</p>
</div><p>Find out more</p>
<div class="lb-trans"><p>了解更多</p>
</div><p>An ongoing outbreak of meningococcal disease at a university in Kent has meant the government is evaluating the vaccine’s broader use. Two people have died as a result of the outbreak, with 20 potential cases.  The UK Health Security Agency (UKHSA) said that a targeted vaccination programme will begin, starting with students residing at the University of Kent. Health secretary Wes Streeting said in the House of Commons that he would ask government advisers to consider expanding the existing schedule to age groups beyond infants, such as teenagers.</p>
<div class="lb-trans"><p>肯特一所大学的脑膜炎球菌病持续爆发，导致政府正在评估疫苗的更广泛使用。此次疫情导致两人死亡，20 个潜在病例。英国卫生安全局（UKHSA）表示，将启动针对性疫苗接种计划，首先针对居住在肯特大学的学生。卫生部长 Wes Streeting 在下议院表示，他将要求政府顾问考虑将现有免疫计划扩展到婴儿以外的年龄组，例如青少年。</p>
</div><p>A GSK spokesperson told <em>Pharmaceutical Technology</em>: “We are ready to engage with any proposals from UK health authorities regarding the broader use of MenB vaccination/Bexsero, to address the current outbreak in Kent. The details of any such proposals are not yet established and so we cannot comment further at this stage.”</p>
<div class="lb-trans"><p>葛兰素史克的一位发言人告诉《制药技术》：&#34;我们准备与英国卫生当局就 MenB 疫苗/Bexsero 的更广泛使用进行接洽，以应对肯特的当前疫情。任何此类提案的细节尚未确定，因此我们目前无法进一步评论。&#34;</p>
</div><p>Meningococcal disease is caused by invasive infection with the bacterium <em>Neisseria meningitidis</em>. The bacteria are transmitted by exhaled droplets or by direct contact with the respiratory secretions of an infected individual. Teenage groups, such as students, are at higher risk of infection because of social culture and group-living arrangements.</p>
<div class="lb-trans"><p>脑膜炎球菌病是由侵袭性感染引起的，病原体为_奈瑟氏脑膜炎球菌_。细菌通过呼吸道分泌物的呼气飞沫或与感染者的呼吸道分泌物直接接触传播。青少年群体，如学生，由于社交文化和群居生活安排，感染风险更高。</p>
</div><p>The MenB vaccine, administered via two doses, has been on the UK routine immunisation programme for babies since 2015 and has led to a 75% reduction in infections for vaccinated groups. Bexsero has been designed to offer broad coverage against most MenB strains causing meningococcal disease, though it cannot offer complete protection, given that new mutations arise.</p>
<div class="lb-trans"><p>MenB 疫苗通过两剂接种，自 2015 年以来一直在英国的婴儿常规免疫计划中使用，并导致接种组的感染减少了 75%。Bexsero 旨在对导致脑膜炎球菌病的大多数 MenB 菌株提供广泛的保护，尽管由于新突变的出现，它无法提供完全的保护。</p>
</div><p>Antibiotics remain the most effective treatment to limit the spread of invasive meningococcal disease. The UKHSA said that over 2,500 doses have been given to students, along with their close contacts, in the Kent area.</p>
<div class="lb-trans"><p>抗生素仍然是限制侵袭性脑膜炎球菌病传播的最有效治疗方法。UKHSA 表示，肯特地区已向学生及其密切接触者提供了超过 2500 剂疫苗。</p>
</div><p>Commenting on the ongoing outbreak, the UKHSA’s chief, Susan Hopkins, said: “This looks like a superspreader event, with ongoing spread within the halls of residents in the universities.”</p>
<div class="lb-trans"><p>在评论当前疫情时，UKHSA 的负责人 Susan Hopkins 表示：&#34;这看起来像是一个超级传播事件，正在大学宿舍内持续传播。&#34;</p>
</div><h2>Private sector’s diminishing supply</h2>
<div class="lb-trans"><h2>私营部门的供应减少</h2>
</div><p>GSK’s MenB vaccine has also been available privately since the jab’s original approval in 2013. Both private surgeries and pharmacies have reported a surge in demand for the vaccine since the outbreak in Kent.</p>
<div class="lb-trans"><p>自 2013 年疫苗首次获批以来，葛兰素史克的 MenB 疫苗也一直可以私下接种。自肯特疫情以来，私人诊所和药店报告了对该疫苗需求的激增。</p>
</div><p>A GP at a private surgery in London, who wished to remain anonymous, told <em>Pharmaceutical Technology</em>: “We’re being inundated with calls. All our vaccine supplies are now used up and we can’t get any more.”</p>
<div class="lb-trans"><p>一位希望保持匿名的伦敦私人诊所的全科医生告诉《制药技术》：&#34;我们接到大量电话。我们所有的疫苗供应现在都用完了，无法再获得更多。&#34;</p>
</div><p>The surgery said it received an alert from its medical supplier, stating: “We have sold out of Bexsero vaccines. Currently, we don’t know when we will be able to get more as priority is given to the NHS.”</p>
<div class="lb-trans"><p>该诊所表示收到了来自其医疗供应商的警报，称：&#34;我们已经售罄 Bexsero 疫苗。目前，我们不知道何时能够获得更多，因为优先权给予 NHS。&#34;</p>
</div><p>Meanwhile, high-street pharmacy chain Superdrug reported a 65-fold increase in booking demand for the vaccine.</p>
<div class="lb-trans"><p>与此同时，连锁药店 Superdrug 报告称，疫苗的预约需求增加了 65 倍。</p>
</div><p>“There is currently a national shortage of the Meningitis B vaccine, and stock is limited. We are working with suppliers to secure more doses,” the company said in a statement.</p>
<div class="lb-trans"><p>“目前脑膜炎 B 疫苗存在全国性短缺，库存有限。我们正在与供应商合作以确保更多剂量，” 该公司在一份声明中表示。</p>
</div>

葛兰素史克准备在英国爆发期间扩展脑膜炎疫苗接种计划